Stabilized receptor polypeptides and uses thereof Grant US-11685770-B2 United States of America 27 Jun 2023
CHK1 (SRA737)/PARPi combination methods of inhibiting tumor growth Grant US-11596637-B2 United States of America 07 Mar 2023
Compositions and methods for treating cancer Grant US-11564913-B2 United States of America 31 Jan 2023
Administration of an anti-activin-A compound to a subject Grant US-11541070-B2 United States of America 03 Jan 2023
Thermo-responsive hydrogel for intratumoral administration as a treatment in solid tumor… Grant US-11534401-B2 United States of America 27 Dec 2022
CD37-binding molecules and immunoconjugates thereof Grant US-11466095-B2 United States of America 11 Oct 2022
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations Grant US-11395796-B2 United States of America 26 Jul 2022
Anti-nucleolin agent-conjugated nanoparticles Grant US-11344633-B2 United States of America 31 May 2022
Methods for improving anti-CD37 immunoconjugate therapy Grant US-11278629-B2 United States of America 22 Mar 2022
Antibodies and assays for detection of CD37 Grant US-11104740-B2 United States of America 31 Aug 2021
Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and MRI and/or X-ray… Grant US-10857237-B2 United States of America 08 Dec 2020
COMPOSITIONS AND METHODS FOR TREATING CANCER Application WO-2020227202-A1 World Intellectual Property Organisation (WIPO) 12 Nov 2020
CHLORIDE-INDUCIBLE PROKARYOTIC EXPRESSION SYSTEM Application WO-2020177857-A1 World Intellectual Property Organisation (WIPO) 10 Sep 2020
ANTISENSE OLIGONUCLEOTIDES OF GLUTATHIONE S-TRANSFERASES FOR CANCER TREATMENT Application WO-2020159349-A2 World Intellectual Property Organisation (WIPO) 06 Aug 2020
CD37-binding molecules and immunoconjugates thereof Grant US-10556958-B2 United States of America 11 Feb 2020
VACCINATION WITH MICROVESICLES DERIVED FROM TUMOUR CELLS FOR CANCER TREATMENT Application WO-2020026001-A1 World Intellectual Property Organisation (WIPO) 06 Feb 2020
Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereof Grant US-10308704-B2 United States of America 04 Jun 2019
A THERMO-RESPONSIVE HYDROGEL FOR INTRATUMORAL ADMINISTRATION AS A TREATMENT IN SOLID… Application WO-2019092049-A1 World Intellectual Property Organisation (WIPO) 16 May 2019
ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES Application EP-3446714-A1 European Patent Office 27 Feb 2019
COMBINED PREPARATIONS OF PKM2 MODULATORS AND HMGB1 Application WO-2017098051-A2 World Intellectual Property Organisation (WIPO) 15 Jun 2017
Variant activin receptor polypeptides, alone or in combination with chemotherapy, and… Grant US-9610327-B2 United States of America 04 Apr 2017
Redox active cerium oxide nanoparticles and associated methods Grant US-9585840-B1 United States of America 07 Mar 2017
ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES AS RADIO-SENSITIZERS AND MRI AND/OR X-RAY… Application WO-2016179394-A1 World Intellectual Property Organisation (WIPO) 10 Nov 2016
Anti-nucleolin agent-conjugated nanoparticles Grant US-9452219-B2 United States of America 27 Sep 2016
ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES Application EP-3011974-A1 European Patent Office 27 Apr 2016
Isolated nucleic acid molecule encoding a fusion protein comprising an activin receptor Grant US-9284364-B2 United States of America 15 Mar 2016
Stabilized receptor polypeptides and uses thereof Grant US-9273114-B2 United States of America 01 Mar 2016
Human monoclonal antibodies to human nucleolin Grant US-9260517-B2 United States of America 16 Feb 2016
Variant activin receptor polypeptides and uses thereof Grant US-8999917-B2 United States of America 07 Apr 2015
Methods of promoting angiogenesis using cerium oxide nanoparticles Grant US-8951539-B1 United States of America 10 Feb 2015
Method for the diagnosis and prognosis of malignant diseases Grant US-8586717-B2 United States of America 19 Nov 2013
USE OF EGFL7 MODULATORS FOR PROMOTING OR INHIBITING MIGRATION OF IMMUNE CELLS ACROSS… Application WO-2013061112-A1 World Intellectual Property Organisation (WIPO) 02 May 2013
ANTI-NUCLEOLIN AGENT-CONJUGATED NANOPARTICLES Application WO-2012167173-A1 World Intellectual Property Organisation (WIPO) 06 Dec 2012
LIPOSOMES COMPRISING AMPHIPATHIC DRUGS AND METHOD FOR THEIR PREPARATION Application WO-2011092708-A2 World Intellectual Property Organisation (WIPO) 04 Aug 2011